Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

[Normal organization of sleep and its changes during life].

Lopez R, Barateau L, Dauvilliers Y.

Rev Prat. 2019 May;69(5):537-545. French.

PMID:
31626464
2.

Clinical autonomic dysfunction in Narcolepsy Type 1.

Barateau L, Chenini S, Evangelista E, Jaussent I, Lopez R, Dauvilliers Y.

Sleep. 2019 Aug 16. pii: zsz187. doi: 10.1093/sleep/zsz187. [Epub ahead of print]

PMID:
31418025
3.

Validation of Multiple Sleep Latency Test for the diagnosis of pediatric narcolepsy type 1.

Pizza F, Barateau L, Jaussent I, Vandi S, Antelmi E, Mignot E, Dauvilliers Y, Plazzi G; MonBo Study Group.

Neurology. 2019 Sep 10;93(11):e1034-e1044. doi: 10.1212/WNL.0000000000008094. Epub 2019 Aug 12.

PMID:
31405906
4.

Clinical neurophysiology of CNS hypersomnias.

Barateau L, Lopez R, Dauvilliers Y.

Handb Clin Neurol. 2019;161:353-367. doi: 10.1016/B978-0-444-64142-7.00060-6.

PMID:
31307613
5.

Shared T cell receptor chains in blood memory CD4+ T cells of narcolepsy type 1 patients.

Beltrán E, Nguyen XH, Quériault C, Barateau L, Dauvilliers Y, Dornmair K, Liblau RS.

J Autoimmun. 2019 Jun;100:1-6. doi: 10.1016/j.jaut.2019.03.010. Epub 2019 Apr 2.

PMID:
30948158
6.

Measurement of symptoms in idiopathic hypersomnia: The Idiopathic Hypersomnia Severity Scale.

Dauvilliers Y, Evangelista E, Barateau L, Lopez R, Chenini S, Delbos C, Beziat S, Jaussent I.

Neurology. 2019 Apr 9;92(15):e1754-e1762. doi: 10.1212/WNL.0000000000007264. Epub 2019 Mar 13.

PMID:
30867266
7.

Exploration of cardiac sympathetic adrenergic nerve activity in narcolepsy.

Barateau L, Lopez R, Chenini S, Evangelista E, Benkiran M, Mariano-Goulart D, Jaussent I, Dauvilliers Y.

Clin Neurophysiol. 2019 Mar;130(3):412-418. doi: 10.1016/j.clinph.2018.11.014. Epub 2018 Dec 6.

PMID:
30573423
8.

Neural network analysis of sleep stages enables efficient diagnosis of narcolepsy.

Stephansen JB, Olesen AN, Olsen M, Ambati A, Leary EB, Moore HE, Carrillo O, Lin L, Han F, Yan H, Sun YL, Dauvilliers Y, Scholz S, Barateau L, Hogl B, Stefani A, Hong SC, Kim TW, Pizza F, Plazzi G, Vandi S, Antelmi E, Perrin D, Kuna ST, Schweitzer PK, Kushida C, Peppard PE, Sorensen HBD, Jennum P, Mignot E.

Nat Commun. 2018 Dec 6;9(1):5229. doi: 10.1038/s41467-018-07229-3.

9.

Reduced brain amyloid burden in elderly patients with narcolepsy type 1.

Gabelle A, Jaussent I, Bouallègue FB, Lehmann S, Lopez R, Barateau L, Grasselli C, Pesenti C, de Verbizier D, Béziat S, Mariano-Goulart D, Carlander B, Dauvilliers Y; Alzheimer's Disease Neuroimaging Initiative; Multi-Domain Intervention Alzheimer's Prevention Trial study groups.

Ann Neurol. 2019 Jan;85(1):74-83. doi: 10.1002/ana.25373. Epub 2018 Dec 19.

PMID:
30387527
10.

Exploring the clinical features of narcolepsy type 1 versus narcolepsy type 2 from European Narcolepsy Network database with machine learning.

Zhang Z, Mayer G, Dauvilliers Y, Plazzi G, Pizza F, Fronczek R, Santamaria J, Partinen M, Overeem S, Peraita-Adrados R, da Silva AM, Sonka K, Rio-Villegas RD, Heinzer R, Wierzbicka A, Young P, Högl B, Bassetti CL, Manconi M, Feketeova E, Mathis J, Paiva T, Canellas F, Lecendreux M, Baumann CR, Barateau L, Pesenti C, Antelmi E, Gaig C, Iranzo A, Lillo-Triguero L, Medrano-Martínez P, Haba-Rubio J, Gorban C, Luca G, Lammers GJ, Khatami R.

Sci Rep. 2018 Jul 13;8(1):10628. doi: 10.1038/s41598-018-28840-w.

11.

Cardiac Sympathetic Activity differentiates Idiopathic and Symptomatic Rapid Eye Movement Sleep Behaviour Disorder.

Barateau L, Jaussent I, Lopez R, Evangelista E, Chenini S, Benkiran M, Mariano-Goulart D, Dauvilliers Y.

Sci Rep. 2018 May 8;8(1):7304. doi: 10.1038/s41598-018-25547-w.

12.

Persistence of deep-tendon reflexes during partial cataplexy.

Barateau L, Pizza F, Lopez R, Antelmi E, Plazzi G, Dauvilliers Y.

Sleep Med. 2018 May;45:80-82. doi: 10.1016/j.sleep.2017.12.011. Epub 2018 Feb 13.

PMID:
29680434
13.

Diagnostic criteria for disorders of arousal: A video-polysomnographic assessment.

Lopez R, Shen Y, Chenini S, Rassu AL, Evangelista E, Barateau L, Jaussent I, Dauvilliers Y.

Ann Neurol. 2018 Feb;83(2):341-351. doi: 10.1002/ana.25153. Epub 2018 Feb 10.

PMID:
29360192
14.

Alternative diagnostic criteria for idiopathic hypersomnia: A 32-hour protocol.

Evangelista E, Lopez R, Barateau L, Chenini S, Bosco A, Jaussent I, Dauvilliers Y.

Ann Neurol. 2018 Feb;83(2):235-247. doi: 10.1002/ana.25141. Epub 2018 Feb 9.

PMID:
29323727
15.

Effect of psychostimulants on blood pressure profile and endothelial function in narcolepsy.

Bosco A, Lopez R, Barateau L, Chenini S, Pesenti C, Pépin JL, Jaussent I, Dauvilliers Y.

Neurology. 2018 Feb 6;90(6):e479-e491. doi: 10.1212/WNL.0000000000004911. Epub 2018 Jan 10.

PMID:
29321233
16.

Test-Retest Reliability of the Multiple Sleep Latency Test in Central Disorders of Hypersomnolence.

Lopez R, Doukkali A, Barateau L, Evangelista E, Chenini S, Jaussent I, Dauvilliers Y.

Sleep. 2017 Dec 1;40(12). doi: 10.1093/sleep/zsx164.

PMID:
29099966
17.

Narcolepsy Type 1 as an Autoimmune Disorder: Evidence, and Implications for Pharmacological Treatment.

Barateau L, Liblau R, Peyron C, Dauvilliers Y.

CNS Drugs. 2017 Oct;31(10):821-834. doi: 10.1007/s40263-017-0464-6. Review.

PMID:
28940143
18.

Depression and Hypersomnia: A Complex Association.

Lopez R, Barateau L, Evangelista E, Dauvilliers Y.

Sleep Med Clin. 2017 Sep;12(3):395-405. doi: 10.1016/j.jsmc.2017.03.016. Epub 2017 May 26. Review.

PMID:
28778237
19.

Narcolepsy and Other Central Hypersomnias.

Dauvilliers Y, Barateau L.

Continuum (Minneap Minn). 2017 Aug;23(4, Sleep Neurology):989-1004. doi: 10.1212/CON.0000000000000492. Review.

PMID:
28777172
20.

[18F]Fludeoxyglucose-Positron Emission Tomography Evidence for Cerebral Hypermetabolism in the Awake State in Narcolepsy and Idiopathic Hypersomnia.

Dauvilliers Y, Evangelista E, de Verbizier D, Barateau L, Peigneux P.

Front Neurol. 2017 Jul 20;8:350. doi: 10.3389/fneur.2017.00350. eCollection 2017.

21.

Author response: Comorbidity between central disorders of hypersomnolence and immune-based disorders.

Dauvilliers Y, Barateau L.

Neurology. 2017 May 2;88(18):1777. doi: 10.1212/WNL.0000000000003901. No abstract available.

PMID:
28461581
22.

Temporal Changes in the Cerebrospinal Fluid Level of Hypocretin-1 and Histamine in Narcolepsy.

Lopez R, Barateau L, Evangelista E, Chenini S, Robert P, Jaussent I, Dauvilliers Y.

Sleep. 2017 Jan 1;40(1). doi: 10.1093/sleep/zsw010.

23.

Measurement of narcolepsy symptoms: The Narcolepsy Severity Scale.

Dauvilliers Y, Beziat S, Pesenti C, Lopez R, Barateau L, Carlander B, Luca G, Tafti M, Morin CM, Billiard M, Jaussent I.

Neurology. 2017 Apr 4;88(14):1358-1365. doi: 10.1212/WNL.0000000000003787. Epub 2017 Mar 3.

24.

Hypersomnolence, Hypersomnia, and Mood Disorders.

Barateau L, Lopez R, Franchi JA, Dauvilliers Y.

Curr Psychiatry Rep. 2017 Feb;19(2):13. doi: 10.1007/s11920-017-0763-0. Review.

PMID:
28243864
25.

Vitamin D deficiency in type 1 narcolepsy: a reappraisal.

Dauvilliers Y, Evangelista E, Lopez R, Barateau L, Scholz S, Crastes de Paulet B, Carlander B, Jaussent I.

Sleep Med. 2017 Jan;29:1-6. doi: 10.1016/j.sleep.2016.05.008. Epub 2016 Sep 29.

PMID:
28153207
26.

Comorbidity between central disorders of hypersomnolence and immune-based disorders.

Barateau L, Lopez R, Arnulf I, Lecendreux M, Franco P, Drouot X, Leu-Semenescu S, Jaussent I, Dauvilliers Y.

Neurology. 2017 Jan 3;88(1):93-100. doi: 10.1212/WNL.0000000000003432. Epub 2016 Nov 18.

PMID:
27864522
27.

Management of Narcolepsy.

Barateau L, Lopez R, Dauvilliers Y.

Curr Treat Options Neurol. 2016 Oct;18(10):43. doi: 10.1007/s11940-016-0429-y. Review.

PMID:
27549768
28.

[CLINICAL INVESTIGATION OF AN EXCESSIVE SLEEPINESS COMPLAINT].

Evangelista E, Barateau L, Dauvilliers Y.

Rev Prat. 2016 Jun;66(6):660-5. French.

PMID:
27538325
29.

Absence of γ-aminobutyric acid-a receptor potentiation in central hypersomnolence disorders.

Dauvilliers Y, Evangelista E, Lopez R, Barateau L, Jaussent I, Cens T, Rousset M, Charnet P.

Ann Neurol. 2016 Aug;80(2):259-68. doi: 10.1002/ana.24710. Epub 2016 Jul 14.

PMID:
27315195
30.

Treatment Options for Narcolepsy.

Barateau L, Lopez R, Dauvilliers Y.

CNS Drugs. 2016 May;30(5):369-79. doi: 10.1007/s40263-016-0337-4. Review.

PMID:
27155860
31.

Absence of NMDA receptor antibodies in the rare association between Type 1 Narcolepsy and Psychosis.

Dauvilliers Y, Gaig C, Barateau L, Graus F, Iranzo A, Lopez R, Santamaria J.

Sci Rep. 2016 May 4;6:25230. doi: 10.1038/srep25230.

32.

Smoking, Alcohol, Drug Use, Abuse and Dependence in Narcolepsy and Idiopathic Hypersomnia: A Case-Control Study.

Barateau L, Jaussent I, Lopez R, Boutrel B, Leu-Semenescu S, Arnulf I, Dauvilliers Y.

Sleep. 2016 Mar 1;39(3):573-80. doi: 10.5665/sleep.5530.

33.

[Sleep disorders in children and adults].

Barateau L, Lopez R, Dauvilliers Y.

Rev Prat. 2014 Oct;64(8):1169-76. French. No abstract available.

PMID:
25510152
34.

Preliminary results on CSF biomarkers for hypothalamic dysfunction in Kleine-Levin syndrome.

Lopez R, Barateau L, Chenini S, Dauvilliers Y.

Sleep Med. 2015 Jan;16(1):194-6. doi: 10.1016/j.sleep.2014.07.022. Epub 2014 Oct 22.

PMID:
25454350

Supplemental Content

Loading ...
Support Center